how long has semaglutide been on the market GLP-1 Agonists Weight Loss Drugs Report, 2025-2030 Semaglutide Biosimilar and Generic Market

A retrospective study of more than 18,000 real-world patients found that those on tirzepatide were more than three times as likely to hit 15% weight loss within a year compared with those on semaglutide

The investigation of oxidative cell death holds promise for the development of pharmacological agents that are used to prevent tumorigenesis or treat established cancer

Gently dab over the bruise with a clean finger or sponge

Avoid providers offering medications without physician evaluation or those making unrealistic promises about results

doi: 10.1056/NEJMoa1800389 24 FabresseN.UteemI.LamyE.MassyZ.LarabiI

Daniel Drucker, a professor at the University of Toronto Faculty of Medicine in Canada and a former adviser to Eli Lilly, said, "It shows the most powerful weight-loss effect among GLP-1 drugs developed so far" and evaluated it as "an effect on par with bariatric surgery (metabolic surgery for obesity)." He added, "If approved, most patients who need substantial weight reduction will choose retatrutide."